Care Pathway Mapping for Dravet Syndrome (DS) Patients in England
A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting
Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers
Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea
Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment
Thinking critically about the value and cost of drugs: managing patients with invasive fungal disease
Managing Mycoplasma genitalium as an STI
The financial and service implications of splitting fixed-dose antiretroviral drugs – a case study
The cost of managing haematology patients with invasive fungal disease
